tirzepatide new law FDA approves tirzepatide, Eli Lilly's type 2 diabetes drug, and the company shares an estimated price Zepbound copycats remain online despite

But like many systems in the body, it can become less reliable due to a variety of factors, including age, diet and other lifestyle habits

Important safety note for people with diabetes: If you are taking insulin or a sulfonylurea alongside any investigational glucose-lowering therapy, improvements in blood glucose control may increase the risk of hypoglycaemia

But regulatory approvals are never guaranteed, and unexpected safety signals can delay or derail the process

Lets explore what current research says about tirzepatide and hypothyroidism, what you should monitor, and how an integrative approach can help you achieve results safely